Baclofen Abuse Signs, Symptoms, and Addiction Treatment

is baclofen addictive

Experienced practitioners point out that withdrawal develops more severely among those who have been administered with intrathecal Gablofen. The primary function of Lioresal in alcohol addiction treatment is to help curb the craving and, as such, increase the dopamine level. Although Lioresal is primarily used as a muscle relaxant to treat spasticity and pain in muscles, it is also used for a few purposes that are not indicated in FDA-approved Baclofen uses. Lioresal comes into play as a drug that allows clients not to feel the compulsion to take alcohol. In the case of mixing Lioresal and alcohol, it can cause dangerous effects in the person who combines them due to the depressant effects of both substances.

  1. Physically being around others can help give individuals the emotional support they need.
  2. If a person misses a dose of baclofen, they should take the dose as soon as they remember.
  3. Preclinical studies have found that baclofen reduces the acquisition of alcohol‐drinking behaviour and its maintenance and reinstatement in alcohol‐experienced rats (Agabio 2014; Colombo 2018).
  4. The professional addiction treatment community is always on the lookout for new, more reliable ways of treating substance use disorders, and research is continually ongoing into various means of medical support for treatment.
  5. Baclofen is indicated in a variety of different areas of addiction treatment, and it may be able to be used for others.

CTRI/2011/11/002154 published data only

We included 17 RCTs involving 1818 participants (see Characteristics of included studies table). The mean study size was 107 participants, ranging from 30 in Leggio 2015 to 320 in Reynaud 2017. Six studies recruited more than 100 participants (Beraha 2016‐LD; Beraha 2016‐LD; Garbutt 2021‐LD; Garbutt 2021‐MD; Hauser 2017; Morley 2018‐LD; Morley 2018‐MD; Reynaud 2017; Rigal 2020). All studies except one recruited participants with a diagnosis of alcohol dependence according to the DSM‐IV or ICD‐10 criteria. To be included, these participants also had to voluntarily consult a physician for their alcohol problem and express the desire to achieve abstinence or reduce alcohol consumption. Accordingly, we assumed that these participants met at least three criteria for AUD (alcohol consumption in higher amounts than intended; desire to cut down or control alcohol use; craving; APA 2013), and we included the study.

Review Of The Current Research Evidence And Clinical Experience

is baclofen addictive

There was no difference between baclofen and naltrexone (RR 0.14, 95% CI 0.01 to 2.45; Analysis 6.6). We identified one study with 60 participants reporting fatigue or tiredness (or both). There was no difference between baclofen and naltrexone (RR 3.00, 95% CI 0.13 to 70.83; Analysis 6.5). There was no difference between baclofen and naltrexone (MD 2.08, 95% CI −3.71 to 7.87; Analysis 6.4).

About Baclofen Withdrawal Symptoms

Aside from its muscle-relaxing properties, Baclofen may also have positive effects on sleep quality for some individuals. By reducing muscle tension and promoting relaxation, Baclofen can contribute to a more restful sleep. We will start by discussing what Baclofen is and its benefits and uses.

is baclofen addictive

When considering buying Baclofen online, it is advisable to choose a reputable online pharmacy that operates within the confines of the law, follows regulatory guidelines, and requires a valid prescription for Baclofen. It is worth mentioning that these common side effects do not occur in everyone taking Baclofen, as individual responses to medication can vary. If any side effect persists, worsens, or becomes concerning, it is recommended to consult with a healthcare professional for further guidance. During the consultation, be open and honest with your healthcare professional, providing them with all necessary information to make an informed decision regarding your prescription. Follow their instructions regarding dosage, frequency, and any additional instructions provided.

It is recommended to take each dose at evenly spaced intervals for consistent effects. One of the main uses of Baclofen is in the treatment of multiple sclerosis (MS), a chronic autoimmune disease that affects the nervous system. MS often leads to muscle https://sober-home.org/how-long-does-marijuana-stay-in-your-system-blood/ spasms and stiffness, and Baclofen can provide relief to individuals experiencing these symptoms. Additionally, Baclofen is effective for treating muscle spasms caused by spinal cord injuries, cerebral palsy, and other neurological conditions.

Baclofen is unlikely to do you any harm if you take it for a long time. But if you have been taking it for a long time do not stop taking it suddenly without checking with your doctor. In these conditions, the muscles shorten (contract) tightly, and can then become stiff and harder to use. Long-term (chronic) muscle stiffness can happen in conditions where the nerves that supply your muscles have been damaged.

There was no difference between baclofen and acamprosate (RR 0.33, 95% CI 0.01 to 7.87; Analysis 5.12). There was no difference between baclofen and acamprosate (RR 0.33, 95% CI 0.01 to 7.87; Analysis 5.11). We identified one study with 60 participants reporting decreased appetite/anorexia. There was no difference between baclofen and acamprosate (RR 1.00, 95% CI 0.15 to 6.64; Analysis 5.10).

Therefore, the pump is prescribed to individuals who have trouble tolerating its oral forms. It is also used in some drug rehabs to treat conditions of mental health caused by alcohol addiction and substance abuse. The medicine works as a supportive treatment by helping patients’ nerves relax. Naltrexone reduced the risk of relapse compared to baclofen (RR 2.50, 95% CI 1.12 to 5.56; very low‐certainty evidence; Analysis 6.1; Table 3). We identified one study with 60 participants reporting dropouts at the end of treatment.

For a detailed description of the reasons supporting our judgements, see the risk of bias table in the Characteristics of included studies table. Placebo, no treatment or any other pharmacological relapse prevention treatment, including acamprosate, naltrexone or nalmefene. We did not consider disulfiram as a control intervention due to the psychological mediation of its effects. Studies could consider baclofen as monotherapy or in combination with further treatments provided that concomitant treatments were provided equally in both the experimental and control groups.

So, whether you are suffering from addiction or you are struggling to maintain freedom from this disorder, we’re here to help. Should this occur in a person’s life, it is absolutely necessary to seek assistance from addiction treatment specialists. Through professional treatment programs, those who suffer from addiction can break free from substance use disorders. The experimental use of baclofen is swiftly catching https://sober-home.org/ on and becoming more and more of a topic of discussion. So, it only seems fitting that, since using this medication for addiction treatment is still in the experimental stage, people would wonder about its qualities and characteristics. Learning about whether or not baclofen is addictive and gaining more information about baclofen withdrawal can be helpful for those who are wondering about this treatment method.

For objective outcomes, we considered 16 studies at low risk of bias and one study at unclear risk (Garbutt 2010b1; Garbutt 2010b2). We judged 13 studies at low risk of bias for objective outcomes and two at high risk (Kumar 2020a; Mishra 2010). Two studies did not provide information about blinding, so we judged them at unclear risk of bias (Garbutt 2010a; Garbutt 2010b1; Garbutt 2010b2). We considered incomplete outcome data (avoidance of attrition bias), for all outcomes except dropout from the treatment, which is very often the primary outcome measure in studies on addiction.

If a person misses a dose of baclofen, they should take the dose as soon as they remember. However, if the next dose is due, a person should skip the missed dose and take the next dose as planned. The doctor will also need to be aware if the person is pregnant, planning on becoming pregnant, or breastfeeding.

We identified one study with 60 participants reporting erectile dysfunction (Kumar 2020a). We identified one study with 60 participants reporting tremor (Kumar 2020a). We excluded people younger than 18 years of age and pregnant women because of the substantially different approach required for clinical management of these individuals. Irrespective of region, AUD is prevalent in more men than women (Glantz 2020), with lifetime prevalence estimated at 14.8% among men and 3.5% among women in the Europe and 11.5% among men and 5.1% among women in the Americas (WHO 2018).

Reasons for downgrading were heterogeneity among study for the outcomes relapse and HDDs and inconsistency for the outcome drinks per drinking days. There were no limitations on other participant characteristics such as concomitant substance use disorders or other comorbid psychiatric conditions. We included participants who were still drinking and those in the postdetoxification phase, if the detoxification was completed 28 days or less before starting treatment. We also included studies with participants in methadone maintenance schemes. We excluded studies where baclofen was used to treat alcohol withdrawal. While several pharmacological treatments have been approved for the treatment of AUD (see Background), their clinical use is limited by a number of factors (Sinclair 2016).

You consent to receive SMS notifications and promotions from Addictionresource. Although the number of cases with Baclofen abuse is growing, it is not on the list of controlled substances. In another study, researchers noted tapering off cravings for nicotine in a patient diagnosed with primary nicotine dependence who does not have any psychiatric disorder. The patient was prescribed to take Lioresal, which he eventually abused. Based on the report, the patient said he experienced an unusual sense of pleasure and well-being whenever he took Lioresal. Currently, studies have not proven that the drug helps with opiate or cannabis addiction.

When it comes to the side effects baclofen use may produce, it is important for individuals to be aware of the ways in which this drug may affect them. It may also cause confusion, physical weakness, or discomfort in the stomach. In severe cases, baclofen use can lead to seizures or breathing problems. As most people with AUD still receive no treatment (Han 2021), the development of new, effective, safe and manageable medications is expected to considerably increase the number of people who seek and receive medical treatment. In addition, RCTs selected by this review took place in different countries including the USA (29.4%); Australia, France, Italy and India (11.8% each); and Germany, Israel, the Netherlands and Russia (5.9% each).

Do not start, stop, or change the dosage of any medicines without your doctor’s approval. The efficacy of the Food and Drug Administration (FDA)-approved medications for alcohol use disorder (AUD) is evidence-based and indisputable [1, 2]. Although not all medications always work for all patients, skepticism often contributes to the lack of their wider use in clinical practice.

In truth, individuals who use baclofen for a while may develop a tolerance for it. Baclofen causes a pleasurable calming effect, which many may grow to desire often. Some individuals may begin to use baclofen outside of the recommended use. Those who wonder about this should not be concerned; medication-assisted treatment involves expert supervision and guidance. However, the question about the addictiveness of baclofen remains viable. Medical professionals did find, however, that baclofen was helpful in minimizing spasticity.

Based on these results, the authors proposed that baclofen may act as a partial substitution AUD medication. A recent pharmaco-fMRI study found that baclofen specifically decreased alcohol cue-reactivity in brain areas involved in the processing of salient (appetitive and aversive) stimuli (77). However, the exact underlying biobehavioral mechanisms of baclofen in AUD individuals are still not completely understood (78–80). Only one RCT using doses of baclofen up to 270 mg/day has been published [(45); Table ​Table1].1]. The results of a second RCT (using up to 300 mg/day) have been presented at scientific meetings but have not yet been published in full (66). Unlike the other two similar RCTs presented above (43, 44), this study found that baclofen substantially increased the percentage of abstinent patients and cumulative abstinence duration compared to placebo [(45); see Table ​Table11].

No Comments